Immunotech Biopharm Ltd

06978

Company Profile

  • Business description

    Immunotech Biopharm Ltd is a cellular immunotherapy biopharmaceutical company in China. The company is focused on the research, development, and commercialization of T-cell immunotherapy. Its product EAL is a multi-target cellular immunotherapy product for the treatment of various types of cancer. Its product pipeline features classes of cellular immunotherapy products, including both non-genetically modified and genetically modified products, as well as both multi-target and single-target products. Its other products include the CAR-T cell series and the TCR-T cell series.

  • Contact

    No.1 Kangding Street
    8th Floor, Block 1, Guosheng Technology Park
    Beijing Economic-technological Development Area
    Beijing100176
    CHN

    T: +86 8610884002

    https://www.eaal.net

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    189

Stocks News & Analysis

stocks

SpaceX is scaling AI infrastructure on earth, data centers in space might be next

Our view on the first results as a publicly traded company.
stocks

Investors too optimistic about overvalued ASX share

Upgraded first-half revenue guidance at the upper end of the previously announced range.
stocks

Restructuring at big four bank

Job cuts create capacity to invest as revenue growth slows.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,956.6012.400.14%
CAC 407,921.6883.191.06%
DAX 4025,645.04340.621.35%
Dow JONES (US)52,856.09360.210.69%
FTSE 10010,752.8819.880.19%
HKSE23,651.87215.87-0.90%
NASDAQ26,702.86278.041.05%
Nikkei 22564,621.24545.820.85%
NZX 50 Index13,832.3671.070.52%
S&P 5007,757.1744.600.58%
S&P/ASX 2008,831.3014.400.16%
SSE Composite Index3,713.0322.34-0.60%

Market Movers